Apatinib Mesylate Combined With IT Regimen for the Treatment of Recurrent or Refractory Pediatric Neuroblastoma: A Single-arm, Phase I/II，Multi-center, Clinical Study.
Clinical trial NCT05027386 · RECRUITING
Trial details
- NCT number
- NCT05027386
- Sponsor
- Sun Yat-sen University
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-08-26
- Primary completion
- 2026-02-04
- Enrollment
- 125
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.